-
Je něco špatně v tomto záznamu ?
MicroRNAs in urine are not biomarkers of multiple myeloma
L. Sedlaříková, L. Bešše, S. Novosadová, V. Kubaczková, L. Radová, M. Staník, M. Krejčí, R. Hájek, S. Ševčíková,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14575
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
BioMedCentral
od 2002-01-12 do 2017-01-12
BioMedCentral Open Access
od 2002
Free Medical Journals
od 2002
Freely Accessible Science Journals
od 2002
PubMed Central
od 2002 do 2017
Europe PubMed Central
od 2002 do 2017
ProQuest Central
od 2009-01-01 do 2017-01-31
Open Access Digital Library
od 2002-09-01
Open Access Digital Library
od 2002-01-01
Open Access Digital Library
od 2002-01-01
Medline Complete (EBSCOhost)
od 2002-09-30 do 2017-08-25
Health & Medicine (ProQuest)
od 2009-01-01 do 2017-01-31
Springer Nature OA/Free Journals
od 2002-12-01 do 2017-12-31
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikro RNA genetika moč MeSH
- mnohočetný myelom diagnóza genetika moč MeSH
- nádorové biomarkery moč MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- stanovení celkové genové exprese metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: In this study, we aimed to identify microRNA from urine of multiple myeloma patients that could serve as a biomarker for the disease. RESULTS: Analysis of urine samples was performed using Serum/Plasma Focus PCR MicroRNA Panel (Exiqon) and verified using individual TaqMan miRNA assays for qPCR. We found 20 deregulated microRNA (p < 0.05); for further validation, we chose 8 of them. Nevertheless, only differences in expression levels of miR-22-3p remained close to statistical significance. CONCLUSIONS: Our preliminary results did not confirm urine microRNA as a potential biomarker for multiple myeloma.
Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Internal Medicine Hematooncology University Hospital Brno Brno Czech Republic
Department of urologic oncology Masaryk Memorial Cancer Institute Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16009954
- 003
- CZ-PrNML
- 005
- 20200219093857.0
- 007
- ta
- 008
- 160408s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12952-015-0035-7 $2 doi
- 024 7_
- $a 10.1186/s12952-015-0035-7 $2 doi
- 035 __
- $a (PubMed)26399230
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Sedlaříková, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. lena.sedlarikova@gmail.com. Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic. lena.sedlarikova@gmail.com. $7 xx0214571
- 245 10
- $a MicroRNAs in urine are not biomarkers of multiple myeloma / $c L. Sedlaříková, L. Bešše, S. Novosadová, V. Kubaczková, L. Radová, M. Staník, M. Krejčí, R. Hájek, S. Ševčíková,
- 520 9_
- $a BACKGROUND: In this study, we aimed to identify microRNA from urine of multiple myeloma patients that could serve as a biomarker for the disease. RESULTS: Analysis of urine samples was performed using Serum/Plasma Focus PCR MicroRNA Panel (Exiqon) and verified using individual TaqMan miRNA assays for qPCR. We found 20 deregulated microRNA (p < 0.05); for further validation, we chose 8 of them. Nevertheless, only differences in expression levels of miR-22-3p remained close to statistical significance. CONCLUSIONS: Our preliminary results did not confirm urine microRNA as a potential biomarker for multiple myeloma.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a nádorové biomarkery $x moč $7 D014408
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a stanovení celkové genové exprese $x metody $7 D020869
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikro RNA $x genetika $x moč $7 D035683
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mnohočetný myelom $x diagnóza $x genetika $x moč $7 D009101
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bešše, Lenka, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. lenka.kubiczek@gmail.com. Department of Hematology and Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland. lenka.kubiczek@gmail.com. $d 1985- $7 mub2014851432
- 700 1_
- $a Novosadová, Soňa $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. 357892@mail.muni.cz.
- 700 1_
- $a Kubaczková, Veronika $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. veronika.kubaczkova@seznam.cz. Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic. veronika.kubaczkova@seznam.cz. $7 xx0214572
- 700 1_
- $a Radová, Lenka $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic. avodar@gmail.com.
- 700 1_
- $a Staník, Michal, $u Department of urologic oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. stanik@mou.cz. $d 1977- $7 xx0141428
- 700 1_
- $a Krejčí, Marta, $u Department of Internal Medicine - Hematooncology, University Hospital Brno, Brno, Czech Republic. mkrejci@fnbrno.cz. $d 1969- $7 jx20080512017
- 700 1_
- $a Hájek, Roman, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. rom.hajek@seznam.cz. Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic. rom.hajek@seznam.cz. Department of Hematooncology, Faculty of Medicine University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic. rom.hajek@seznam.cz. $d 1964- $7 nlk20000083645
- 700 1_
- $a Ševčíková, Sabina, $d 1972- $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. sevcik@med.muni.cz. Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic. sevcik@med.muni.cz. $7 mub2015859787
- 773 0_
- $w MED00008238 $t Journal of negative results in biomedicine $x 1477-5751 $g Roč. 14, č. - (2015), s. 16
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26399230 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20200219094300 $b ABA008
- 999 __
- $a ok $b bmc $g 1113383 $s 934322
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 14 $c - $d 16 $e 20150923 $i 1477-5751 $m Journal of negative results in biomedicine $n J Negat Results Biomed $x MED00008238
- GRA __
- $a NT14575 $p MZ0
- LZP __
- $a Pubmed-20160408